The O’Neal Comprehensive Cancer Center at UAB is recruiting Alabama women who have never had breast cancer for the study, to test a personalized approach to breast cancer screening.
The Altec Styslinger Genomic Medicine and Data Sciences Building will help cement UAB’s place as a leading research institution in genomic and precision medicine.
Partnership with the PathCheck Foundation, founded at MIT in Cambridge, Ma., will enable other states and countries to use UAB-created exposure verification technology for exposure notification.
The partnership pairs the company's technical and operational expertise with UAB Medicine's clinical expertise as a national leader in pulmonary and critical care medicine.
Project ECHO links medical professionals with an expert in a particular field in an interactive video format to boost learning and, ultimately, patient care.
Cancer centers nationwide, including the O’Neal Comprehensive Cancer Center at UAB as a leading site, are joining together to address the impact of COVID-19 pandemic on cancer prevention and treatment.
There is a narrow window of opportunity for successfully treating major cardiovascular events, and patients risk serious consequences if they wait for symptoms to get worse before seeking medical attention.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.